U.S. FDA Grants Paige Breakthrough Device Designation for Cancer Detection in Breast Lymph Nodes
Paige Lymph Node is recognized by the FDA as a breakthrough device to assist pathologists in the detection of breast cancer metastases in lymph node tissue
United States Davids Klimstra Andy Moye Paige Fullfocus Drug Administration Breakthrough Device Designation
Source: itnonline.com